JNJ up +0.42% percent Today $JNJ High is at 108.69 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 1:33 PM

JNJ up +0.42% percent Today $JNJ High is at 108.69 and the Low 107.61 with current volume of 894,784.

Recent News posted below.

Johnson & Johnson JNJ other info.
http://investorshangout.com/Johnson--Johnson-JNJ-51518/

JNJ Johnson & Johnson Recent Headline News

DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - 2 hrs 17 mins ago
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 108.30 (+0.14), ABT: 43.90 (+0.09), DXCM: 52.34 (-0.39), MDT: 69.54 (+0.59)

Early Glance: Medical Devices companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.54 (+0.59), BAX: 71.99 (+0.24)

Early Glance: Pharmaceuticals companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)

5 Rocket Stocks to Buy as Earnings Season Ends: Southwest Airlines and More
at The Street - Mon Nov 17, 9:17AM CST
From a momentum standpoint, stocks are well-positioned to keep up their upside action as we head into the final stretch of 2014.
JNJ: 108.30 (+0.14), ORLY: 177.64 (-2.24), ED: 62.52 (+0.49), LUV: 39.45 (+0.50), CRM: 62.82 (-1.09)

Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.30 (+0.14), GILD: 100.44 (-1.62), ABBV: 65.14 (+1.14), CELG: 104.66 (+0.61)

Forget Marijuana! This Is a Much Smarter Investment
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 16, 11:11AM CST
Source: Flickr user Oswaldo. Although marijuana initiatives didn't log a perfect sweep in this year's midterm elections, the momentum behind the legalization movement remains intact. Two states (Oregon and Alaska), as well as Washington, D.C.,...
JNJ: 108.30 (+0.14), INSY: 38.50 (-0.07), GWPH: 75.31 (-0.32), GSK: 45.93 (+0.19), NVS: 94.54 (+0.59)

Value Investors' Most Loved Stocks In Q3 2014
Trading Mates Stock Advisor - at Seeking Alpha - Sun Nov 16, 8:09AM CST

NOV: 71.80 (+0.46), JNJ: 108.30 (+0.14), IBM: 164.48 (+0.32), WMT: 83.51 (+0.55), BAC: 17.07 (-0.07), BEN: 56.30 (-0.08), ACN: 84.69 (+0.05), SLB: 95.98 (+0.66), ORCL: 41.18 (+0.34)

3 Ways High-Yield Dividend Stocks Can Help You Recreate Warren Buffett's Investing Success
Adam Galas, The Motley Fool - Motley Fool - Sat Nov 15, 6:05PM CST
Many people consider Warren Buffett the greatest investor in history and it's not hard to understand why. According to a 2012 Yale study, Buffett's company, Berkshire Hathaway , had the best risk-adjusted return of any company or mutual fund that...
KMI: 39.99 (+0.62), MMM: 159.04 (+0.19), JNJ: 108.30 (+0.14), LNCO: 20.39 (-0.54), IBM: 164.48 (+0.32), WFC: 53.39 (+0.04), SDRL: 20.86 (+0.08), PG: 87.78 (-0.33), LINE: 22.37 (-0.28), VNR: 23.93 (-0.55), CL: 67.81 (+0.25)

Johnson & Johnson Part VI: 'Magic Pants' And 'Doubling Pennies'
Robert Honeywill - Seeking Alpha - Sat Nov 15, 6:00AM CST
In Part V of this series, I provided 4 scenarios (8 Cases) illustrating the potential financial outcomes for investors in Johnson & Johnson (NYSE: JNJ ) under changing PE ratios, which are a reflection of changing share prices and changing...
JNJ: 108.30 (+0.14)

Retirement Strategy: Annuities Vs. Dividend Growth Investing For A Lifetime Income
Regarded Solutions - at Seeking Alpha - Fri Nov 14, 11:01PM CST

KO: 42.94 (+0.21), T: 35.90 (unch), JNJ: 108.30 (+0.14), GE: 26.65 (+0.19), XOM: 95.04 (-0.05), MCD: 95.84 (-0.37), PG: 87.77 (-0.34), CVX: 115.98 (-0.34), AAPL: 114.00 (-0.18), WAG: 66.24 (-0.69)

Final Glance: Pharmaceuticals companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)

Final Glance: Medical Devices companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.53 (+0.58), BAX: 71.99 (+0.24)

Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 304.67 (-0.76), JNJ: 108.30 (+0.14), GERN: 3.02 (+0.26), AFFX: 9.39 (-0.32)

Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 39.30 (-0.50), AMZN: 321.03 (-6.79), JNJ: 108.30 (+0.14), HTZ: 22.17 (+0.48), GERN: 3.02 (+0.26), HAL: 49.82 (-5.26), JWN: 73.33 (-0.84), NOK: 7.66 (-0.20), BHI: 66.27 (+6.38)

Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.30 (+0.14), GERN: 3.02 (+0.26)

Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:39PM CST
Mallinckrodt (MNK) received a setback when the FDA informed the company that its methylphenidate hydrochloride extended-release tablets, USP (CII) might not be therapeutically equivalent to Johnson & Johnson's (JNJ) Concerta.
MNK: 88.39 (+0.28), BIIB: 304.67 (-0.76), JNJ: 108.30 (+0.14), ACT: 247.01 (+3.24)

Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 39.30 (-0.50), JNJ: 108.30 (+0.14), HTZ: 22.17 (+0.48), VA: 30.98 (+0.98), GERN: 3.02 (+0.26), JWN: 73.33 (-0.84)

Midday Glance: Pharmaceuticals companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)

Midday Glance: Medical Devices companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.53 (+0.58), BAX: 71.99 (+0.24)

Johnson & Johnson (JNJ) Stock Research Links

JNJ Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WareSpace Expands Reach With $36.5M Acquisitions

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

EnGenius Names Experienced VP to Boost Sales Growth

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Celebrating Appalachian Soul with Aristotle Jones

Igniting a Celebration of Appalachian Soul Now here's a sound that hits you right in the gut. Aristotle Jones, known out there as the 'Appalachian Soul Man,' is making a big move. He's laying out the plan to make July the Appalachian Soul Month. This fellow isn't shy about celebrating the deep roots of Appalachian music, dropping his album Appalachian Soul Power and a new...

Omneky Integrates AI Growth Agent With Slack for Ads

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

American Savings Bank Surges 6% on NYSE Debut

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Guaranteed Roof Expands with EM Exteriors through LB Capital

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Metriport Eyes Major Step in Health Data Integration

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Airswift's Strategic Acquisition Boosts U.S. Energy Presence

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Piedmont Orthopedics Expands Care in Henry County

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...